PCVX FY 2019 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$8B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$54M

Net Income

-$50M

EPS (Diluted)

$-14.10

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$66M

Total Liabilities

$172M

Stockholders' Equity

-$106M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-18.8%
Operating Income	-$54M	-$36M	-52.4%
Net Income	-$50M	-$29M	-70.5%